The burden of disease and injury in the United States 1996

被引:132
|
作者
Michaud C.M. [1 ]
McKenna M.T. [2 ]
Begg S. [3 ]
Tomijima N. [4 ]
Majmudar M. [5 ]
Bulzacchelli M.T. [6 ]
Ebrahim S. [2 ]
Ezzati M. [1 ]
Salomon J.A. [1 ]
Kreiser J.G.
Hogan M. [3 ]
Murray C.J.L. [1 ]
机构
[1] Harvard Initiative for Global Health, Harvard University, Cambridge, MA 02138
[2] Center for Disease Control and Prevention, Atlanta, GA 30333
[3] School of Population Health, The University of Queensland, Brisbane, QLD
[4] Columbia University in the City of New York, New York, NY 10027-6902
[5] Haas School of Business, University of California, Berkeley, CA 94720-1900
[6] Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205
关键词
Ischaemic Heart Disease; Motor Vehicle Accident; Hypertensive Heart Disease; Disability Weight; Mortality Burden;
D O I
10.1186/1478-7954-4-11
中图分类号
学科分类号
摘要
Background: Burden of disease studies have been implemented in many countries using the Disability-Adjusted Life Year (DALY) to assess major health problems. Important objectives of the study were to quantify intra-country differentials in health outcomes and to place the United States situation in the international context. Methods: We applied methods developed for the Global Burden of Disease (GBD) to data specific to the United States to compute Disability-Adjusted Life Years. Estimates are provided by age and gender for the general population of the United States and for each of the four official race groups: White; Black; American Indian or Alaskan Native; and Asian or Pacific Islander. Several adjustments of GBD methods were made: the inclusion of race; a revised list of causes; and a revised algorithm to allocate cardiovascular disease garbage codes to ischaemic heart disease. We compared the results of this analysis to international estimates published by the World Health Organization for developed and developing regions of the world. Results: In the mid-1990s the leading sources of premature death and disability in the United States, as measured by DALYs, were: cardiovascular conditions, breast and lung cancers, depression, osteoarthritis, diabetes mellitus, and alcohol use and abuse. In addition, motor vehicle-related injuries and the HIV epidemic exacted a substantial toll on the health status of the US population, particularly among racial minorities. The major sources of death and disability in these latter populations were more similar to patterns of burden in developing rather than developed countries. Conclusion: Estimating DALYs specifically for the United States provides a comprehensive assessment of health problems for this country compared to what is available using mortality data alone. © 2006 Michaud et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [21] The income-associated burden of disease in the United States
    Muennig, P
    Franks, P
    Jia, HM
    Lubetkin, E
    Gold, MR
    SOCIAL SCIENCE & MEDICINE, 2005, 61 (09) : 2018 - 2026
  • [22] Burden of liver disease in the United States: Summary of a workshop
    Kim, WR
    Brown, RS
    Terrault, NA
    El-Serag, H
    HEPATOLOGY, 2002, 36 (01) : 227 - 242
  • [23] Economic Burden of Legionnaires' Disease, United States, 2014
    Baker-Goering, Madeleine
    Roy, Kakoli
    Edens, Chris
    Collier, Sarah
    EMERGING INFECTIOUS DISEASES, 2021, 27 (01) : 255 - 257
  • [24] THE ECONOMIC BURDEN OF SICKLE CELL DISEASE IN THE UNITED STATES
    Huo, J.
    Xiao, H.
    Garg, M.
    Shah, C.
    Wilkie, D. J.
    Mainous, A., III
    VALUE IN HEALTH, 2018, 21 : S108 - S108
  • [25] Burden of Nonalcoholic Fatty Liver Disease (NAFLD) in the United States
    Sanyal, Arun J.
    Estes, Chris
    Razavi, Homie
    HEPATOLOGY, 2016, 64 : 532A - 532A
  • [26] The economic burden of noncervical human papillomavirus disease in the United States
    Hu, Delphine
    Goldie, Sue
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (05) : 500.e1 - 500.e7
  • [27] THE FUTURE BURDEN OF HEART DISEASE IN EUROPE, JAPAN, AND THE UNITED STATES
    Atella, V
    Belotti, F.
    Chapel, J.
    Hashimoto, H.
    Kasajima, M.
    Peneva, D.
    Mortari, Piano A.
    Tysinger, B.
    Van Nuys, K.
    VALUE IN HEALTH, 2020, 23 : S493 - S493
  • [28] Burden of cardiorenal disease in the United States general adult population
    Cataliotti, A
    Redfield, MM
    Rodeheffer, RJ
    Heublein, DM
    Sandberg, SM
    Jacobsen, SJ
    Bailey, KR
    Mahoney, DW
    Burnett, JC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 209A - 209A
  • [29] The national economic burden of rare disease in the United States in 2019
    Grace Yang
    Inna Cintina
    Anne Pariser
    Elisabeth Oehrlein
    Jamie Sullivan
    Annie Kennedy
    Orphanet Journal of Rare Diseases, 17
  • [30] The Economic Burden of Parkinson's Disease (PD) in the United States
    Tanner, C.
    Albin, R.
    Dahodwala, N.
    Dorsey, R.
    Yang, W.
    Schmiel, L.
    Cintina, I.
    Kopil, C.
    Beck, J.
    Hamilton, J.
    MOVEMENT DISORDERS, 2019, 34 : S760 - S761